WO2008105902A3 - Nouvelles nanoparticules pour ciblage de biofilm - Google Patents

Nouvelles nanoparticules pour ciblage de biofilm Download PDF

Info

Publication number
WO2008105902A3
WO2008105902A3 PCT/US2007/073529 US2007073529W WO2008105902A3 WO 2008105902 A3 WO2008105902 A3 WO 2008105902A3 US 2007073529 W US2007073529 W US 2007073529W WO 2008105902 A3 WO2008105902 A3 WO 2008105902A3
Authority
WO
WIPO (PCT)
Prior art keywords
novel nanoparticles
biofilm
targeting
biofilm targeting
nanoparticles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/073529
Other languages
English (en)
Other versions
WO2008105902A2 (fr
Inventor
Trevor Douglas
Mark J Young
Peter Suci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Montana State University Bozeman
Original Assignee
Montana State University Bozeman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Montana State University Bozeman filed Critical Montana State University Bozeman
Publication of WO2008105902A2 publication Critical patent/WO2008105902A2/fr
Publication of WO2008105902A3 publication Critical patent/WO2008105902A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/38011—Tombusviridae
    • C12N2770/38022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/38011—Tombusviridae
    • C12N2770/38023—Virus like particles [VLP]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne de nouvelles compositions et des procédés utilisant des nanoparticules comprenant des cages protéiques pour la délivrance d'agents antimicrobiens et d'imagerie à des colonies bactériennes de formation de biofilm.
PCT/US2007/073529 2006-07-14 2007-07-13 Nouvelles nanoparticules pour ciblage de biofilm Ceased WO2008105902A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83083006P 2006-07-14 2006-07-14
US60/830,830 2006-07-14

Publications (2)

Publication Number Publication Date
WO2008105902A2 WO2008105902A2 (fr) 2008-09-04
WO2008105902A3 true WO2008105902A3 (fr) 2008-10-23

Family

ID=39721744

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/073529 Ceased WO2008105902A2 (fr) 2006-07-14 2007-07-13 Nouvelles nanoparticules pour ciblage de biofilm

Country Status (1)

Country Link
WO (1) WO2008105902A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8541006B2 (en) 2007-07-30 2013-09-24 University Of Maryland, Baltimore Methods and devices for the detection of biofilm
EP2335073A4 (fr) 2008-09-02 2012-09-26 Univ Maryland Diagnostic d'infection de biofilm in vivo et traitement
GB0817507D0 (en) * 2008-09-24 2008-10-29 Ucl Business Plc Protein cages
US8535477B2 (en) 2009-02-21 2013-09-17 Sofradim Production Medical devices incorporating functional adhesives
CA2804263A1 (fr) 2010-06-29 2012-01-12 Tyco Healthcare Group Lp Reacteur alimente par micro-ondes et methode de formation in situ d'implants
EP2588153A2 (fr) 2010-07-01 2013-05-08 Sofradim Production Dispositif médical comportant une intégration cellulaire activée prédéfinie
US9775928B2 (en) 2013-06-18 2017-10-03 Covidien Lp Adhesive barbed filament

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030175246A1 (en) * 2001-12-18 2003-09-18 Schaak Diane L. Toxin-phage bacteriocide antibiotic and uses thereof
US20040115132A1 (en) * 2002-05-17 2004-06-17 Young Mark J. Protein cages for the delivery of medical imaging and therapeutic agents
US20060014136A1 (en) * 2004-07-14 2006-01-19 Inimex Pharmaceuticals, Inc. Method of screening for protection from microbial infection

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030175246A1 (en) * 2001-12-18 2003-09-18 Schaak Diane L. Toxin-phage bacteriocide antibiotic and uses thereof
US20040115132A1 (en) * 2002-05-17 2004-06-17 Young Mark J. Protein cages for the delivery of medical imaging and therapeutic agents
US20060014136A1 (en) * 2004-07-14 2006-01-19 Inimex Pharmaceuticals, Inc. Method of screening for protection from microbial infection

Also Published As

Publication number Publication date
WO2008105902A2 (fr) 2008-09-04

Similar Documents

Publication Publication Date Title
WO2007130655A3 (fr) Activités antimicrobiennes dérivées de bactériophages
WO2008105902A3 (fr) Nouvelles nanoparticules pour ciblage de biofilm
WO2011080132A3 (fr) Composé, compositions et procédés de lutte contre les biofilms
AU2016204543A1 (en) Targeted antimicrobial moieties
WO2009100456A3 (fr) Inhibition et traitement de biofilms gastro-intestinaux
WO2007109604A3 (fr) Compositions pharmaceutiques
WO2008030988A3 (fr) Peptides antimicrobiens ciblés sélectivement et leur utilisation
WO2008048288A3 (fr) Nouvelles nanoparticules et leur utilisation
WO2008112368A3 (fr) Agents de distribution d'acide phénylalkylcarboxylique
EP2730576A3 (fr) Composés anti-infectieux
MX2010004341A (es) Producto para el cuidado oral y metodo de uso y fabricacion del mismo.
WO2007127841A3 (fr) Compositions et leurs méthodes d'élaboration
MA32876B1 (fr) Anticorps dirigés contre l'angiopoïétine 2 humaine
PL1981915T3 (pl) Kompozycje składników aktywnych
WO2007117433A3 (fr) Compositions antimicrobiennes comprenant des sels alcalins d'acide de houblon et leurs utilisations
WO2013102021A3 (fr) Composition désinfectante à faible ph
WO2010059529A3 (fr) Compositions comprenant un arylpyrazole et/ou une formamidine, procédés et utilisations de celles-ci
WO2011071904A3 (fr) Inhibition des infections bactériennes et de la formation de biofilms
WO2008010991A3 (fr) Méthodes et compositions pour le traitement du cancer
WO2009121970A3 (fr) Matériau stratifié
WO2008006514A8 (fr) Combinaisons de principes actifs ayant des propriétés insecticides et acaricides
WO2007097981A3 (fr) Alpha carbolines et leurs utilisations
WO2009130616A3 (fr) Compositions agonistes de tlr3 améliorées
AU2010306647A8 (en) Antimicrobial compounds and methods of making and using the same
EP2545933A3 (fr) Procédés et compositions visant à améliorer les propriétés pharmacologiques ciblant le système nerveux

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07873766

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07873766

Country of ref document: EP

Kind code of ref document: A2